AN2 Therapeutics, Inc.ANTXNASDAQ
Loading
Year-over-year operating cash flow growth rate
Latest
39.43%
↑ 158% vs avg
Percentile
P100
Near historical high
Streak
4 yr
Consecutive growthAccelerating
Average
-67.61%
Historical baseline
| Period | Value |
|---|---|
| 2025 | 39.43% |
| 2024 | 7.56% |
| 2023 | -59.25% |
| 2022 | -63.36% |
| 2021 | -281.88% |
| 2020 | -115.77% |
| 2019 | 0.00% |